Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Incidence of Second Malignant Neoplasms (SMN) after Haematopoetic Stem Cell Transplant.

Samar Kulkarni, MRCP, Michael Potter, MRCPath, Mark Ethell, PRCPath, Radovan Saso, PhD, Jennifer Treleaven, FRCPath, Joy Brennan, BSc, Pawel Kaczmarek, MRCP, Prashant Hiwarkar, MRCP, Pamala Kanagasabapathy, MRCP, Caroline Alvares, MRCPath, Clive Horton, PhD, Raymond Powles, FRCP, Frank Saran, FRCR, Gareth Morgan, FRCPath

Blood (2006) 108 (11): 551.

https://doi.org/10.1182/blood.V108.11.551.551

Published: 2006

Journal Articles

Lymphocyte Count on Day 56 Predicts for Reduced Risk of Infection Related Mortality Following Non-Myeloablative Allogeneic Haematopoietic Stem Cell Transplantation.

Caroline Alvares, MRCPath, Samar Kulkarni, MRCP, Pawel Kaczmarek, PhD, Radovan Saso, PhD, Helena Woods, Joy Brennan, BSc, Clive Horton, PhD, Jennifer Treleaven, FRCPath, Mark Ethell, MRCPath, Claire Dearden, MRCPath, Gareth Morgan, FRCPath, Michael Potter, FRCPath

Blood (2006) 108 (11): 5324.

https://doi.org/10.1182/blood.V108.11.5324.5324

Published: 2006

Journal Articles

Pregnancy Outcome Following Haematopoietic Stem Cell Transplantation.

Samar Kulkarni, MRCP, Mark Ethell, MRCPath, Jennifer Treleaven, FRCPath, Radovan Saso, PhD, Joy Brennan, BsC, Pawel Kaczmarek, PhD, Caroline Alvares, MRCPATH, Clive Horton, PhD, Frank Saran, FRCR, Pamala Kanagasabapathy, MRCP, Prashant Hiwarkar, MRCP, Stella Appiah-Cubi, MRCP, Moez Dungarwala, MRCP, Raymond Powles, FRCP, Gareth Morgan, FRCPath, Michael Potter, FRCPath

Blood (2006) 108 (11): 3367.

https://doi.org/10.1182/blood.V108.11.3367.3367

Published: 2006

Journal Articles

Responses to Induction Chemotherapy and High Dose Melphalan Can Be Incorporated within a Risk Stratification Model and Help to Identify Myeloma Patients Who May Benefit from Novel Therapies.

Caroline L. Alvares, Faith E. Davies, Clive Horton, Gita Patel, Roslin Zuha, Alex Gatt, Radovan Saso, Jennifer Treleaven, Mark Ethell, Mike Potter, Claire Dearden, Gareth J. Morgan

Blood (2004) 104 (11): 2394.

https://doi.org/10.1182/blood.V104.11.2394.2394

Published: 2004

Journal Articles

Recipient CMV Seropositivity Predicts Relapse Post Allogeneic Transplantation in Children.

Roslin Zuha, MRCP, MRCPATH, Alex Gatt, MRCP, MRCPATH, Caroline Alvares, MRCP, MRCPATH, Clive Horton, Gita Patel, Mark Ethell, MRCP, MRCPATH, Michael Potter, FRCP, FRCPATH

Blood (2004) 104 (11): 5140.

https://doi.org/10.1182/blood.V104.11.5140.5140

Published: 2004

Journal Articles

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants

Samar Kulkarni, Ray Powles, Jennie Treleaven, Unell Riley, Seema Singhal, Clive Horton, Bhawna Sirohi, Niyati Bhagwati, Simon Meller, Radovan Saso, Jayesh Mehta

Blood (2000) 95 (12): 3683–3686.

https://doi.org/10.1182/blood.V95.12.3683

Published: 2000

Journal Articles

Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation

Ray Powles, Seema Singhal, Jennifer Treleaven, Samar Kulkarni, Clive Horton, Jayesh Mehta

Blood (1998) 91 (9): 3481–3486.

https://doi.org/10.1182/blood.V91.9.3481

Published: 1998

Journal Articles

Number of Nucleated Cells Infused During Allogeneic and Autologous Bone Marrow Transplantation: An Important Modifiable Factor Influencing Outcome

Jayesh Mehta, Ray Powles, Jennie Treleaven, Samar Kulkarni, Clive Horton, Seema Singhal

Blood (1997) 90 (9): 3808–3810.

https://doi.org/10.1182/blood.V90.9.3808

Published: 1997

Journal Articles

Growth of Human T-Cell Lineage Acute Leukemia in Severe Combined Immunodeficiency (SCID) Mice and Non-obese Diabetic SCID Mice

Jeremy P.C. Steele, Robyn D. Clutterbuck, Ray L. Powles, Paul L.R. Mitchell, Clive Horton, Ricardo Morilla, Daniel Catovsky, John L. Millar

Blood (1997) 90 (5): 2015–2019.

https://doi.org/10.1182/blood.V90.5.2015

Published: 1997

Journal Articles

Leukocyte Recovery and Early Treatment-Related Mortality After Bone Marrow Transplantation

Jayesh Mehta, Ray Powles, Clive Horton, Jennifer Treleaven, Seema Singhal

Blood (1997) 89 (11): 4237.

https://doi.org/10.1182/blood.V89.11.4237

Published: 1997

NARROW

Incidence of Second Malignant Neoplasms (SMN) after Haematopoetic Stem Cell Transplant.

Lymphocyte Count on Day 56 Predicts for Reduced Risk of Infection Related Mortality Following Non-Myeloablative Allogeneic Haematopoietic Stem Cell Transplantation.

Pregnancy Outcome Following Haematopoietic Stem Cell Transplantation.

Responses to Induction Chemotherapy and High Dose Melphalan Can Be Incorporated within a Risk Stratification Model and Help to Identify Myeloma Patients Who May Benefit from Novel Therapies.

Recipient CMV Seropositivity Predicts Relapse Post Allogeneic Transplantation in Children.

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants

Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation

Number of Nucleated Cells Infused During Allogeneic and Autologous Bone Marrow Transplantation: An Important Modifiable Factor Influencing Outcome

Growth of Human T-Cell Lineage Acute Leukemia in Severe Combined Immunodeficiency (SCID) Mice and Non-obese Diabetic SCID Mice

Leukocyte Recovery and Early Treatment-Related Mortality After Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only